Burroughs Amy L.
Transaction: 05/28/2026
BUY
Change
+120,000
Price
$0.80
Filing
05/29/2026
Type
BUY
Tenaya Therapeutics, Inc.
TNYA • Biotechnology
$0.68
▼ -0.01 (-1.74%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$104.51M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.09Healthy liquidity · 6.84Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 6, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.68
Change-1.74%
Shares Out152.97M
Market Cap$104.51M
Enterprise Value$33.74M
52W Range0.53 - 2.35
Beta2.82
P/E-1.26
P/S464.49
P/B0.98
P/FCF-1.62
EV/Sales149.96
Price$0.68
Change-1.74%
Shares Out152.97M
Market Cap$104.51M
Enterprise Value$33.74M
52W Range0.53 - 2.35
Beta2.82
P/E-1.26
P/S464.49
P/B0.98
P/FCF-1.62
EV/Sales149.96
EV/EBITDA-0.44
EV/FCF-0.52
Earnings Yield-79.42%
FCF Yield-61.84%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.09
Current Ratio6.84
Quick Ratio6.84
Target$2.00
Target Upside192.74%
Target Median$2.00
Target Range2.00 - 2.00
Volume1.60M
Avg Volume3.67M
EPS Surprise0.00
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.09Healthy liquidity · 6.84Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 6 analyst votes · 2026-09-05
100/100
Bullish
Bullish
6
Hold
0
Bearish
0
Price Target
2026-06-30
Low
$2.00
Mean
$2.00
Median
$2.00
High
$2.00
Insider Transactions
Recent executive and insider activity
⚠ 6 high-volume insider sells detected
Lee June
Transaction: 05/28/2026
BUY
Change
+120,000
Price
$0.80
Filing
05/29/2026
Type
BUY
Parschauer Karah Herdman
Transaction: 05/28/2026
BUY
Change
+120,000
Price
$0.80
Filing
05/29/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Burroughs Amy L. | BUY | +120,000 | $0.80 | 05/28/2026 | 05/29/2026 |
| Lee June | BUY | +120,000 | $0.80 | 05/28/2026 | 05/29/2026 |
| Parschauer Karah Herdman | BUY | +120,000 | $0.80 | 05/28/2026 | 05/29/2026 |
| Srivastava Deepak | BUY | +120,000 | $0.80 | 05/28/2026 | 05/29/2026 |
| Stehman-Breen Catherine | BUY | +120,000 | $0.80 | 05/28/2026 | 05/29/2026 |
| Walsh Jeffrey T. | BUY | +120,000 | $0.80 | 05/28/2026 | 05/29/2026 |
| Williams R Sanders | BUY | +120,000 | $0.80 | 05/28/2026 | 05/29/2026 |
| Higa Tomohiro | SELL | -1,485 | $0.79 | 05/18/2026 | 05/19/2026 |
| Tingley Whittemore | SELL | -3,121 | $0.79 | 05/18/2026 | 05/19/2026 |
| Ali Faraz | SELL | -3,390 | $0.79 | 05/18/2026 | 05/19/2026 |
| COLUMN GROUP III GP, LP | SELL | -1,862,545 | $0.56 | 02/25/2026 | 02/26/2026 |
| COLUMN GROUP III GP, LP | SELL | -309,228 | $0.62 | 02/24/2026 | 02/26/2026 |
| COLUMN GROUP III GP, LP | SELL | -143,709 | $0.60 | 02/23/2026 | 02/24/2026 |
| COLUMN GROUP III GP, LP | SELL | -245,965 | $0.61 | 02/20/2026 | 02/24/2026 |
| Tingley Whittemore | SELL | -1,876 | $0.64 | 02/17/2026 | 02/17/2026 |
| Ali Faraz | SELL | -5,032 | $0.64 | 02/17/2026 | 02/17/2026 |
| Higa Tomohiro | SELL | -2,022 | $0.64 | 02/17/2026 | 02/17/2026 |
| COLUMN GROUP III GP, LP | SELL | -1,905,115 | $0.68 | 02/11/2026 | 02/12/2026 |
| COLUMN GROUP III GP, LP | SELL | -161,422 | $0.82 | 02/10/2026 | 02/12/2026 |
| Ali Faraz | BUY | +158,600 | Not reported | 02/03/2026 | 02/05/2026 |